INDUCTION1
SKYRIZI DOSING
Administration Considerations: SKYRIZI is intended for use under the guidance and supervision of a healthcare professional (HCP). SKYRIZI vial for intravenous administration is intended for administration by an HCP. Prior to starting therapy, please refer to the Dosage and Administration section of the Prescribing Information for complete information on how to initiate, prepare, and administer SKYRIZI. Patients may self-inject SKYRIZI using the On-Body Injector with prefilled cartridge after training in subcutaneous injection technique. Provide proper training to patients and/or caregivers on the subcutaneous injection technique of SKYRIZI according to the Instructions for Use.1
IV=intravenous; NDC=national drug code; SC=subcutaneous; UC=ulcerative colitis.
RELIABLE 2-MONTH MAINTENANCE DOSING AFTER 3 IV INFUSIONS FOR UC AND CROHN’S DISEASE1
Maintenance doses administered in the office or at home1
3 IV Infusions
1200 mg
per dose in UC
600 mg
per dose in Crohn’s
Administer each dose of SKYRIZI over at least 2 hours in UC and 1 hour in Crohn’s
UC dose: 2 cartons of SKYRIZI 600 mg/10 mL: NDC 0074-5015-01
Crohn’s dose: 1 carton of SKYRIZI 600 mg/10 mL: NDC 0074-5015-01
MAINTENANCE1
Only 6 SC Doses Per Year
(180 mg/1.2 mL or 360 mg/2.4 mL)
Use the lowest effective dosage to maintain therapeutic response
SKYRIZI 180 mg/1.2 mL: NDC 0074-1065-01 (kit)
SKYRIZI 360 mg/2.4 mL: NDC 0074-1070-01 (kit)
Administration Considerations: SKYRIZI is intended for use under the guidance and supervision of a healthcare professional (HCP). SKYRIZI vial for intravenous administration is intended for administration by an HCP. Prior to starting therapy, please refer to the Dosage and Administration section of the Prescribing Information for complete information on how to prepare and administer SKYRIZI. Patients may self-inject SKYRIZI using the on-body injector with prefilled cartridge after training in subcutaneous injection technique. Provide proper training to patients and/or caregivers on the subcutaneous injection technique of SKYRIZI according to the Instructions for Use.1
IV=intravenous; NDC=National Drug Code; SC=subcutaneous.
RECOMMENDED FOR YOU
SKYRIZI ACCESS & REIMBURSEMENT
AbbVie can help your patients access SKYRIZI.
SKYRIZI ON-BODY INJECTOR
See how it works and what patients had to say about it.
INFORMATION FOR YOUR SKYRIZI PATIENTS
Help patients start and stay on track with SKYRIZI.
RECOMMENDED FOR YOU
SKYRIZI ACCESS & REIMBURSEMENT
AbbVie can help your patients access SKYRIZI.
SKYRIZI ON-BODY INJECTOR
See how it works and what patients had to say about it.
INFORMATION FOR YOUR SKYRIZI PATIENTS
Help patients start and stay on track with SKYRIZI.
